BioCentury
ARTICLE | Company News

C.R. Bard, SenoRx Inc. deal

May 17, 2010 7:00 AM UTC

C.R. Bard Inc. (NYSE:BCR), Murray Hill, N.J. SenoRx Inc. (NASDAQ:SENO), Irvine, Calif. Business: Cancer Bard plans to acquire SenoRx for $11 per share in cash, which values the company at $193.1 mill...